Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913207981> ?p ?o ?g. }
- W2913207981 endingPage "63" @default.
- W2913207981 startingPage "63" @default.
- W2913207981 abstract "In this study, a transferrin (Tf)-conjugated polymeric nanoparticle was developed for the targeted delivery of the chemotherapeutic agent doxorubicin (Dox) in order to overcome multi-drug resistance in cancer treatment. Our objective was to improve Dox delivery for producing significant antitumor efficacy in Dox-resistant (R) breast cancer cell lines with minimum toxicity to healthy cells. The results of our experiments revealed that Dox was successfully loaded inside a transferrin (Tf)-conjugated polymeric nanoparticle composed of poloxamer 407 (F127) and 123 (P123) (Dox/F127&P123-Tf), which produced nanosized particles (~90 nm) with a low polydispersity index (~0.23). The accelerated and controlled release profiles of Dox from the nanoparticles were characterized in acidic and physiological pH and Dox/F127&P123-Tf enhanced Dox cytotoxicity in OVCAR-3, MDA-MB-231, and MDA-MB-231(R) cell lines through induction of cellular apoptosis. Moreover, Dox/F127&P123-Tf inhibited cell migration and altered the cell cycle patterns of different cancer cells. In vivo study in MDA-MB-231(R) tumor-bearing mice demonstrated enhanced delivery of nanoparticles to the tumor site when coated in a targeting moiety. Therefore, Dox/F127&P123-Tf has been tailored, using the principles of nanotherapeutics, to overcome drug-resistant chemotherapy." @default.
- W2913207981 created "2019-02-21" @default.
- W2913207981 creator A5000807125 @default.
- W2913207981 creator A5007318614 @default.
- W2913207981 creator A5025121789 @default.
- W2913207981 creator A5026064781 @default.
- W2913207981 creator A5026896278 @default.
- W2913207981 creator A5034418015 @default.
- W2913207981 creator A5044288629 @default.
- W2913207981 creator A5066449360 @default.
- W2913207981 creator A5083751923 @default.
- W2913207981 creator A5085961215 @default.
- W2913207981 creator A5086090575 @default.
- W2913207981 date "2019-02-01" @default.
- W2913207981 modified "2023-10-16" @default.
- W2913207981 title "Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells" @default.
- W2913207981 cites W1761238376 @default.
- W2913207981 cites W1818353405 @default.
- W2913207981 cites W1968351069 @default.
- W2913207981 cites W1978267970 @default.
- W2913207981 cites W2033413353 @default.
- W2913207981 cites W2042162620 @default.
- W2913207981 cites W2065600081 @default.
- W2913207981 cites W2105553762 @default.
- W2913207981 cites W2126358907 @default.
- W2913207981 cites W2217342753 @default.
- W2913207981 cites W2238025595 @default.
- W2913207981 cites W2261296848 @default.
- W2913207981 cites W2317217839 @default.
- W2913207981 cites W2334618377 @default.
- W2913207981 cites W2402725798 @default.
- W2913207981 cites W2405973915 @default.
- W2913207981 cites W2415468972 @default.
- W2913207981 cites W2460350660 @default.
- W2913207981 cites W2461689898 @default.
- W2913207981 cites W2515278375 @default.
- W2913207981 cites W2556387887 @default.
- W2913207981 cites W2561853431 @default.
- W2913207981 cites W2566415791 @default.
- W2913207981 cites W2570878808 @default.
- W2913207981 cites W2573184299 @default.
- W2913207981 cites W2578126608 @default.
- W2913207981 cites W2592539277 @default.
- W2913207981 cites W2593485598 @default.
- W2913207981 cites W2604269760 @default.
- W2913207981 cites W2605158646 @default.
- W2913207981 cites W2605847570 @default.
- W2913207981 cites W2605856916 @default.
- W2913207981 cites W2611827085 @default.
- W2913207981 cites W2612383308 @default.
- W2913207981 cites W2616001229 @default.
- W2913207981 cites W2616171786 @default.
- W2913207981 cites W2618606694 @default.
- W2913207981 cites W2625193474 @default.
- W2913207981 cites W2729960294 @default.
- W2913207981 cites W2736425644 @default.
- W2913207981 cites W2752243232 @default.
- W2913207981 cites W2753321571 @default.
- W2913207981 cites W2766897340 @default.
- W2913207981 cites W2769404797 @default.
- W2913207981 cites W2769418059 @default.
- W2913207981 cites W2771408946 @default.
- W2913207981 cites W2771603006 @default.
- W2913207981 cites W2779287116 @default.
- W2913207981 cites W2794015470 @default.
- W2913207981 cites W2803289916 @default.
- W2913207981 cites W2803815851 @default.
- W2913207981 cites W2804830635 @default.
- W2913207981 cites W2885461960 @default.
- W2913207981 cites W2904658120 @default.
- W2913207981 cites W817808178 @default.
- W2913207981 cites W952105760 @default.
- W2913207981 cites W2602172970 @default.
- W2913207981 doi "https://doi.org/10.3390/pharmaceutics11020063" @default.
- W2913207981 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6410246" @default.
- W2913207981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30717256" @default.
- W2913207981 hasPublicationYear "2019" @default.
- W2913207981 type Work @default.
- W2913207981 sameAs 2913207981 @default.
- W2913207981 citedByCount "73" @default.
- W2913207981 countsByYear W29132079812019 @default.
- W2913207981 countsByYear W29132079812020 @default.
- W2913207981 countsByYear W29132079812021 @default.
- W2913207981 countsByYear W29132079812022 @default.
- W2913207981 countsByYear W29132079812023 @default.
- W2913207981 crossrefType "journal-article" @default.
- W2913207981 hasAuthorship W2913207981A5000807125 @default.
- W2913207981 hasAuthorship W2913207981A5007318614 @default.
- W2913207981 hasAuthorship W2913207981A5025121789 @default.
- W2913207981 hasAuthorship W2913207981A5026064781 @default.
- W2913207981 hasAuthorship W2913207981A5026896278 @default.
- W2913207981 hasAuthorship W2913207981A5034418015 @default.
- W2913207981 hasAuthorship W2913207981A5044288629 @default.
- W2913207981 hasAuthorship W2913207981A5066449360 @default.
- W2913207981 hasAuthorship W2913207981A5083751923 @default.
- W2913207981 hasAuthorship W2913207981A5085961215 @default.
- W2913207981 hasAuthorship W2913207981A5086090575 @default.
- W2913207981 hasBestOaLocation W29132079811 @default.